85,164 Shares in ARK Genomic Revolution ETF $ARKG Purchased by Himension Capital Singapore PTE. LTD.

Himension Capital Singapore PTE. LTD. bought a new stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 85,164 shares of the company’s stock, valued at approximately $2,250,000. Himension Capital Singapore PTE. LTD. owned approximately 0.19% of ARK Genomic Revolution ETF as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. lifted its holdings in shares of ARK Genomic Revolution ETF by 30.6% in the fourth quarter. JPMorgan Chase & Co. now owns 5,149,454 shares of the company’s stock worth $149,180,000 after buying an additional 1,205,541 shares in the last quarter. Morgan Stanley boosted its holdings in ARK Genomic Revolution ETF by 42.2% in the 4th quarter. Morgan Stanley now owns 4,025,965 shares of the company’s stock valued at $116,632,000 after purchasing an additional 1,193,795 shares during the period. BNP Paribas Financial Markets grew its position in shares of ARK Genomic Revolution ETF by 49.7% during the 4th quarter. BNP Paribas Financial Markets now owns 3,514,980 shares of the company’s stock valued at $101,829,000 after purchasing an additional 1,167,558 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of ARK Genomic Revolution ETF by 29.1% during the 4th quarter. Wells Fargo & Company MN now owns 1,287,390 shares of the company’s stock valued at $37,296,000 after purchasing an additional 290,301 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in shares of ARK Genomic Revolution ETF by 185.0% in the fourth quarter. Royal Bank of Canada now owns 445,592 shares of the company’s stock worth $12,910,000 after purchasing an additional 289,237 shares during the period.

ARK Genomic Revolution ETF Trading Up 3.3%

Shares of ARKG stock opened at $39.56 on Wednesday. ARK Genomic Revolution ETF has a 52-week low of $22.73 and a 52-week high of $44.47. The business’s fifty day moving average is $36.26 and its 200 day moving average is $31.73.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.